MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Replimune Group, Inc.

REPL

#2301
Replimune Group, Inc.
7.65
-2.30%
Sector:
Básica:
Profit Currency:
Rango diario
7.65
7.65
Rango anual
2.68
13.24
Cambio diario
-2.30%
Monthly Change
+1.73%
6 month change
+37.84%
Cambio anual
-39.04%
Cierres anteriores
7.83
Open
7.65
Bid
Ask
Low
7.65
High
7.65
Volumen
97
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. REPL
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Noticias

Seeking Alpha Seeking Alpha
REPL
2026.02.21
Replimune Stock: Multiple Shots On Goal But A High Risk Binary Approaches (NASDAQ:REPL)
Zacks Zacks
REPL
2026.02.12
Wall Street Analysts Predict a 65.72% Upside in Replimune Group (REPL): Here's What You Should Know
Zacks Zacks
BMY ANIP CRMD REPL
2025.12.31
Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months
Seeking Alpha Seeking Alpha
INCY ABVX MDGL ALKS IMTX
2025.12.16
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Seeking Alpha Seeking Alpha
REGN ALNY NVS AZN ARVN
2025.11.27
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
Benzinga Benzinga
WEN CMBM LCID HTZ SOC
2025.11.26
The Short List — Top 10 Most Shorted Stocks Right Now - Lucid Group (NASDAQ:LCID)
Seeking Alpha Seeking Alpha
IOVA REPL IMTX
2025.11.24
Iovance Biotherapeutics: Several Positives, But Competition Still Threatens (NASDAQ:IOVA)
Investing Investing
REPL
2025.11.12
Cantor Fitzgerald mantiene calificación de Mejor Rendimiento para acciones de Replimune Group
Investing Investing
REPL
2025.11.12
Cantor Fitzgerald mantiene calificación de Sobreponderación para acciones de Replimune
Investing Investing
REPL
2025.11.12
Cantor Fitzgerald reiterates Overweight rating on Replimune Group stock
Investing Investing
REPL
2025.11.07
Replimune presenta datos positivos para tratamiento de melanoma en SITC 2025
Investing Investing
REPL
2025.11.07
Replimune presenta datos positivos para tratamiento de melanoma en SITC 2025

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd